The Efficacy, Safety And Toleration Of CP-866,087 In Pre-Menopausal Women With Female Sexual Arousal Disorder.

NCT00482664 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Sexual Dysfunction, Physiological

Interventions

DRUG: CP-866,087
DRUG: CP-866,087
DRUG: CP-866,087
DRUG: Placebo

Sponsor

Pfizer